Cargando…

Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy

BACKGROUND: Patients with pancreatic ductal adenocarcinoma (PDAC) who undergo surgical resection and receive effective chemotherapy have the best chance for long‐term survival. Unfortunately, because of the heterogeneity of pancreatic cancer, it is difficult to find a personalized treatment strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Miaomiao, Meng, Han, Tan, Dengxu, Li, Peng, Qin, Jing, An, Qingling, Shi, Changhong, An, Jiaze
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Themed Section: Usage of Different Tumor Models in Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614126/ https://www.ncbi.nlm.nih.gov/pubmed/37890865 http://dx.doi.org/10.1002/ame2.12352

Ejemplares similares

Establishment of image‐guided radiotherapy of orthotopic hepatocellular carcinoma mouse model
por: Zhou, Kaixiao, et al.
Publicado: (2023)

A cadaveric breast cancer tissue phantom for phase‐contrast X‐ray imaging applications
por: Rounds, Cody C., et al.
Publicado: (2023)

Cellular and molecular characteristics of the premetastatic niches
por: Liu, Hongfei, et al.
Publicado: (2023)

Progress in building clinically relevant patient‐derived tumor xenograft models for cancer research
por: Wang, Weijing, et al.
Publicado: (2023)

Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models
por: Tan, Dengxu, et al.
Publicado: (2022)

A brief history of organoids
por: Corrò, Claudia, et al.
Publicado: (2020)

Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis
por: de Rooij, Thijs, et al.
Publicado: (2015)

The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma
por: Korrel, M., et al.
Publicado: (2020)

Mechanisms of drug resistance of pancreatic ductal adenocarcinoma at different levels
por: Du, Jiali, et al.
Publicado: (2020)

Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Farshadi, Elham Aida, et al.
Publicado: (2021)

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
por: de Santiago, Ines, et al.
Publicado: (2019)

The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
por: Low, Ronnie Ren Jie, et al.
Publicado: (2021)

Gastrointestinal organoids: a next-generation tool for modeling human development
por: Singh, Akaljot, et al.
Publicado: (2020)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC)
por: Redegalli, M., et al.
Publicado: (2022)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
por: Lof, Sanne, et al.
Publicado: (2019)

THU507 Tumor Activin A Mediates Cachexia Primarily Through White Adipose Tissue Hydrolysis In Pancreatic Ductal Adenocarcinoma
por: Yu, Seok-Yeong, et al.
Publicado: (2023)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
por: Lau, Allison N, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)
por: Xiang, Zi-jun, et al.
Publicado: (2020)

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance
por: Zou, Xuan, et al.
Publicado: (2023)

Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma
por: Sahakyan, Mushegh A., et al.
Publicado: (2021)

Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
por: Li, Tianjiao, et al.
Publicado: (2019)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
por: Croft, Wayne, et al.
Publicado: (2023)

The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping
por: Lautizi, Manuela, et al.
Publicado: (2022)

Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry
por: Brouwer, Thomas P, et al.
Publicado: (2022)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Interactions between malaria and human immunodeficiency virus anno 2014
por: Van geertruyden, J-P
Publicado: (2014)

Endophthalmitis
por: Durand, M L
Publicado: (2013)

Skirts as Flags: Transitional Justice, Gender and Everyday Nationalism in Kosovo
por: Krasniqi, Vjollca, et al.
Publicado: (2020)

Modelling in infectious diseases: between haphazard and hazard
por: Neuberger, A., et al.
Publicado: (2013)

Web‐based participatory surveillance of infectious diseases: the Influenzanet participatory surveillance experience
por: Paolotti, D., et al.
Publicado: (2013)

The microarray technology: facts and controversies
por: Lévêque, N., et al.
Publicado: (2012)

Biological warfare, bioterrorism, and biocrime
por: Jansen, H. J., et al.
Publicado: (2014)

Applying proteomic technology to clinical virology
por: Mancone, C., et al.
Publicado: (2012)

The global burden of bacterial and viral zoonotic infections
por: Christou, L.
Publicado: (2011)

Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma
por: Yu, Xiang, et al.
Publicado: (2017)

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
por: Strijker, Marin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_38t8d10792pv98vkim8r9l3l50